These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


469 related items for PubMed ID: 36235607

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway.
    Cong F, Liu J, Wang C, Yuan Z, Bi L, Liang J, Su K, Qiu Y, Song T, Fan J, Chao G.
    Biomed Pharmacother; 2017 Aug; 92():927-934. PubMed ID: 28605877
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF-κB pathway.
    Li Y, Zhuang Q, Tao L, Zheng K, Chen S, Yang Y, Feng C, Wang Z, Shi H, Shi J, Fang Y, Xiao L, Geng D, Wang Z.
    Cell Prolif; 2022 Oct; 55(10):e13291. PubMed ID: 35708050
    [Abstract] [Full Text] [Related]

  • 8. Norisoboldine suppresses osteoclast differentiation through preventing the accumulation of TRAF6-TAK1 complexes and activation of MAPKs/NF-κB/c-Fos/NFATc1 Pathways.
    Wei ZF, Tong B, Xia YF, Lu Q, Chou GX, Wang ZT, Dai Y.
    PLoS One; 2013 Oct; 8(3):e59171. PubMed ID: 23536866
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast.
    Hong SE, Lee J, Seo DH, In Lee H, Ri Park D, Lee GR, Jo YJ, Kim N, Kwon M, Shon H, Kyoung Seo E, Kim HS, Young Lee S, Jeong W.
    Free Radic Biol Med; 2017 Nov; 112():191-199. PubMed ID: 28774817
    [Abstract] [Full Text] [Related]

  • 11. GSH attenuates RANKL-induced osteoclast formation in vitro and LPS-induced bone loss in vivo.
    Han B, Geng H, Liu L, Wu Z, Wang Y.
    Biomed Pharmacother; 2020 Aug; 128():110305. PubMed ID: 32485573
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
    Chen G, Xu Q, Dai M, Liu X.
    Biochem Biophys Res Commun; 2019 Feb 05; 509(2):329-334. PubMed ID: 30579598
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.
    He L, Lee J, Jang JH, Lee SH, Nan MH, Oh BC, Lee SG, Kim HH, Soung NK, Ahn JS, Kim BY.
    Bone; 2012 Jun 05; 50(6):1207-13. PubMed ID: 22484180
    [Abstract] [Full Text] [Related]

  • 16. Monotropein Protects against Inflammatory Bone Loss and Suppresses Osteoclast Formation and Bone Resorption by Inhibiting NFATc1 via NF-κB and Akt/GSK-3β Pathway.
    Zhang Q, Hu S, He Y, Song Z, Shen Y, Zhao Z, Zhang Q, Qin L, Zhang Q.
    Nutrients; 2022 Sep 24; 14(19):. PubMed ID: 36235631
    [Abstract] [Full Text] [Related]

  • 17. Plastrum testudinis extract suppresses osteoclast differentiation via the NF-κB signaling pathway and ameliorates senile osteoporosis.
    Chen H, Shen G, Shang Q, Zhang P, Yu D, Yu X, Zhang Z, Zhao W, Wu Z, Tang F, Liang D, Jiang X, Ren H.
    J Ethnopharmacol; 2021 Aug 10; 276():114195. PubMed ID: 33974944
    [Abstract] [Full Text] [Related]

  • 18. Esculetin attenuates receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation through c-Fos/nuclear factor of activated T-cells c1 signaling pathway.
    Baek JM, Park SH, Cheon YH, Ahn SJ, Lee MS, Oh J, Kim JY.
    Biochem Biophys Res Commun; 2015 May 29; 461(2):334-41. PubMed ID: 25887803
    [Abstract] [Full Text] [Related]

  • 19. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J.
    J Bone Miner Res; 2012 Jun 29; 27(6):1298-1308. PubMed ID: 22337253
    [Abstract] [Full Text] [Related]

  • 20. Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis.
    Ye X, Jiang J, Yang J, Yan W, Jiang L, Chen Y.
    Acta Biochim Biophys Sin (Shanghai); 2022 Aug 25; 54(8):1080-1089. PubMed ID: 35929595
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.